NO20030868D0 - N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid - Google Patents

N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid

Info

Publication number: NO20030868D0
Authority: NO; Norway
Prior art keywords: benzenesulfonamide; piperazin; methoxyphenyl; dichloro; methoxy
Prior art date: 2000-08-31

Application number

NO20030868A

Other languages

English (en)

Other versions

NO20030868L (no

Inventor

Steven Mark Bromidge

Stephen Frederick Moss

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-31

Filing date

2003-02-25

Publication date

2003-02-25

2003-02-25 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2003-02-25 Publication of NO20030868D0 publication Critical patent/NO20030868D0/no

2003-04-04 Publication of NO20030868L publication Critical patent/NO20030868L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20030868A 2000-08-31 2003-02-25 N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid NO20030868L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0021450.2A GB0021450D0 (en)	2000-08-31	2000-08-31	Novel compounds
PCT/EP2001/009927 WO2002018358A1 (en)	2000-08-31	2001-08-27	N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide

Publications (2)

Publication Number	Publication Date
NO20030868D0 true NO20030868D0 (no)	2003-02-25
NO20030868L NO20030868L (no)	2003-04-04

Family

ID=9898634

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030868A NO20030868L (no)	2000-08-31	2003-02-25	N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid

Country Status (16)

Country	Link
US (1)	US20040034036A1 (no)
EP (1)	EP1313720A1 (no)
JP (1)	JP2004507530A (no)
KR (1)	KR20030024919A (no)
CN (1)	CN1449391A (no)
AU (1)	AU2001284041A1 (no)
BR (1)	BR0113650A (no)
CA (1)	CA2420935A1 (no)
CZ (1)	CZ2003579A3 (no)
GB (1)	GB0021450D0 (no)
HU (1)	HUP0300863A2 (no)
IL (1)	IL154675A0 (no)
MX (1)	MXPA03001783A (no)
NO (1)	NO20030868L (no)
PL (1)	PL361300A1 (no)
WO (1)	WO2002018358A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0204720D0 (en) *	2002-02-28	2002-04-17	Glaxo Group Ltd	Novel use
SI1497266T1 (sl)	2002-03-27	2008-10-31	Glaxo Group Ltd	Derivati kinolina in njihova uporaba kot ligandi 5-ht6
NZ544331A (en)	2003-07-22	2010-03-26	Arena Pharm Inc	Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
EP1976495A2 (en) *	2006-01-06	2008-10-08	Aarhus Universitet	Compounds acting on the serotonin transporter
US20100041672A1 (en) *	2007-03-21	2010-02-18	Glaxo Group Limited	Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
EP2254564A1 (en)	2007-12-12	2010-12-01	Glaxo Group Limited	Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en)	2008-04-02	2011-01-27	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en)	2008-10-28	2010-06-03	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
CN105085436B (zh)	2014-04-19	2019-08-16	广东东阳光药业有限公司	磺酰胺类衍生物及其在药物上的应用
RU2017145976A (ru)	2015-06-12	2019-07-15	Аксовант Сайенсиз Гмбх	Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
AU2016291673A1 (en)	2015-07-15	2018-01-25	Axovant Sciences Gmbh	Diaryl and arylheteroaryl urea derivatives for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2296033A1 (en) *	1997-07-11	1999-01-21	Smithkline Beecham P.L.C.	Novel compounds
GB9803411D0 (en) *	1998-02-18	1998-04-15	Smithkline Beecham Plc	Novel compounds

2000
- 2000-08-31 GB GBGB0021450.2A patent/GB0021450D0/en not_active Ceased
2001
- 2001-08-27 KR KR10-2003-7002896A patent/KR20030024919A/ko not_active Application Discontinuation
- 2001-08-27 CZ CZ2003579A patent/CZ2003579A3/cs unknown
- 2001-08-27 HU HU0300863A patent/HUP0300863A2/hu unknown
- 2001-08-27 PL PL36130001A patent/PL361300A1/xx not_active Application Discontinuation
- 2001-08-27 CA CA002420935A patent/CA2420935A1/en not_active Abandoned
- 2001-08-27 BR BR0113650-0A patent/BR0113650A/pt not_active Application Discontinuation
- 2001-08-27 IL IL15467501A patent/IL154675A0/xx unknown
- 2001-08-27 EP EP01962980A patent/EP1313720A1/en not_active Withdrawn
- 2001-08-27 JP JP2002523476A patent/JP2004507530A/ja active Pending
- 2001-08-27 MX MXPA03001783A patent/MXPA03001783A/es not_active Application Discontinuation
- 2001-08-27 AU AU2001284041A patent/AU2001284041A1/en not_active Abandoned
- 2001-08-27 CN CN01814785A patent/CN1449391A/zh active Pending
- 2001-08-27 US US10/362,789 patent/US20040034036A1/en not_active Abandoned
- 2001-08-27 WO PCT/EP2001/009927 patent/WO2002018358A1/en not_active Application Discontinuation
2003
- 2003-02-25 NO NO20030868A patent/NO20030868L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1313720A1 (en)	2003-05-28
HUP0300863A2 (hu)	2003-09-29
WO2002018358A1 (en)	2002-03-07
IL154675A0 (en)	2003-09-17
AU2001284041A1 (en)	2002-03-13
CN1449391A (zh)	2003-10-15
JP2004507530A (ja)	2004-03-11
BR0113650A (pt)	2004-02-10
GB0021450D0 (en)	2000-10-18
US20040034036A1 (en)	2004-02-19
CA2420935A1 (en)	2002-03-07
NO20030868L (no)	2003-04-04
MXPA03001783A (es)	2003-06-04
PL361300A1 (en)	2004-10-04
KR20030024919A (ko)	2003-03-26
CZ2003579A3 (cs)	2003-09-17

Publication	Publication Date	Title
DE60131971D1 (de)	2008-01-31	1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
MX242679B (es)	2006-12-14	Antranilamidas insecticidas.
FI20000004A0 (fi)	2000-01-03	Flavonoidilääke...
DE50114386D1 (de)	2008-11-20	Ng
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE50107988D1 (de)	2005-12-15	Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
NO20030868D0 (no)	2003-02-25	N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
CH695519A5 (de)	2006-06-15	Sperrstromthyristor.
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es)	2003-04-16	Antitranspirantes
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos
DE50107204D1 (de)	2005-09-29	8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
AR027974A1 (es)	2003-04-23	1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
AT500246B8 (de)	2007-02-15	Chokerring
IS7131A (is)	2004-01-29	Nýjar 2,4-díamínóþíasól afleiður
ATA11602000A (de)	2005-10-15	Sonnenstandsnachführungssystem
ATA12252000A (de)	2002-01-15	Regensinkkasten
ATA17542000A (de)	2002-08-15	Hydraulikzylinder
ATA19392000A (de)	2004-01-15	Kippflügelflugzeug
PT9613T (pt)	2001-09-27	Vysor 3 d
IS7299A (is)	2004-06-03	3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
UA3773S (uk)	2000-10-16	Шрифт
ITRC20000004V0 (it)	2000-07-17	Deodorante - souvenir "i calandreddhi"
ES1045935Y (es)	2001-04-16	Pupitre-silla mejorado.

Legal Events

Date	Code	Title	Description
2005-05-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application